why choose us

First received: July 25, 2023

Clinical Trial: CW2IP2: Imaging and Diagnostic Assessments

Study Status: Completed

Recruit Status: RECRUITING

Condition: Tauopathies

Study Type: INTERVENTIONAL


Official Title: Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Imaging and Diagnostic Assessments

Brief Summary: This current protocol will provide the key data to help determine the specificity of our to-be-developed radiotracers by implementing a multi-site diagnostic assessment core and PET imaging of A-beta amyloid (may be completed at some sites as part of another protocol) that is commonly deposited in the brains of people with Parkinson's Disease (PD), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) or Frontotemporal Dementia (FTD) as well as healthy controls.This multicenter U19 grant is…

Read more